Magnetic Sentinel Lymph Node Biopsy
The future of cancer staging
![grandmother, mother, and daughter smile together](./media_16cc62b2a81c80f6ca159204d3e5bb4a810a6e478.jpeg?width=750&format=jpeg&optimize=medium)
Sentinel Lymph Node Biopsy
Sentinel Lymph Node Biopsy (SLNB) has been widely accepted as the replacement for axillary lymph node dissection as the staging procedure for early node-negative breast cancer. Traditionally SLNB involves injecting radioactive drugs which are dependent on nuclear medicine availability and blue dyes that can put a patient at risk for anaphylaxis and skin necrosis.1,2
Magnetic Sentinel Lymph Node Biopsy
Magnetic SLNB uses a single tracer that offers the freedom to be injected in the operating room or up to thirty days beforehand to improve scheduling and the patient experience.
![Older woman smiles at another older woman](./media_1f6288b57f64059ebe0bee024cbc588012dd1a201.jpeg?width=750&format=jpeg&optimize=medium)
Magnetic sentinel lymph node biopsy with the sentimagĀ® localization platform
![](./media_1b04e04d292ae6c421036b8dcd0203186ee43aa81.jpeg?width=750&format=jpeg&optimize=medium)
MagtraceĀ® Lymphatic Tracer
Engineered to be uniform and small enough for rapid migration, yet large enough to be mechanically filtered by the sentinel lymph nodes.
![](./media_17eb8ef51e60efde68f5ccbef0621dde55459a37f.png?width=750&format=png&optimize=medium)
SentimagĀ® Localization Platform
Four techniques in one platform allow for more surgical options than any other non-gamma localization system.